William P Forbes Heron Therapeutics, Inc. (HRTX) insider trading activity

HRTX Quotes by TradingView

William P Forbes is EVP, Chief Development Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 95,374 shares of HRTX, which is worth approximately $309,965. The most recent transaction as insider was on Jun 06, 2024, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 95.4K
15.08% 3M change
n/a 12M change
Total Value Held $309,965

William P Forbes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Exercise of conversion of derivative security
-
12,500 Added 11.59%
95,374 Common Stock
Apr 19 2024
BUY
Exercise of conversion of derivative security
-
3,874 Added 4.47%
82,874 Common Stock
Nov 17 2023
BUY
Open market or private purchase
$27,250 $1.09 p/Share
25,000 Added 24.04%
79,000 Common Stock
Nov 16 2023
BUY
Open market or private purchase
$47,000 $0.94 p/Share
50,000 Added 48.08%
54,000 Common Stock

Also insider at

TRVI
Trevi Therapeutics, Inc. Healthcare
Chief Development Officer
XAIR
Beyond Air, Inc. Healthcare
Director
WPF

William P Forbes

EVP, Chief Development Officer
New Haven, CT

Track Institutional and Insider Activities on HRTX

Follow HERON THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

News

Receive news related to HERON THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRTX